Mesentech is a company focused on treating diseases and medical conditions that relate to bone.
Mesentech's investors include Merck, Creative Destruction Lab, Propel(X), FedDev, CureDuchenne Ventures.
Mesentech is headquartered in Vancouver, Canada.
Mesentech is a company focused on treating diseases and medical conditions that relate to bone.
Mesentech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mesentech — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/mesentech. Accessed August 14, 2026.
VCBacked. (2023). Mesentech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mesentech
{{cite web |title=Mesentech — Funding & Investors |url=https://www.vcbacked.co/company/mesentech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated